Mikhail Kostylev

Mikhail Kostylev serves as an Associate Research Scientist in the Department of Neuroscience at Yale School of Medicine. His research focuses on the molecular mechanisms underlying Alzheimer's disease, particularly examining the interactions between amyloid-β oligomers, prion proteins, and cellular signaling pathways.

Dr. Kostylev's research interests center on neurodegenerative diseases, with particular emphasis on Alzheimer's disease pathophysiology. His work investigates how amyloid-β oligomers interact with cellular prion protein to trigger synaptic dysfunction through metabotropic glutamate receptor 5 (mGluR5) and downstream signaling pathways. His laboratory employs molecular biology, biochemistry, and transgenic mouse models to understand the conformational changes in proteins that contribute to neurodegeneration. Recent work has explored liquid-liquid phase separation phenomena in prion proteins and how polymeric antagonists might rescue Alzheimer's pathophysiology.

Analysis of Dr. Kostylev's publication record reveals a consistent focus on the molecular mechanisms of Alzheimer's disease spanning over a decade. His work demonstrates an evolution from characterizing basic protein interactions to developing potential therapeutic interventions. The research shows particular strength in identifying key molecular players in Alzheimer's pathogenesis and translating these findings into potential treatment strategies, with recent publications focusing on protein conformation dynamics and novel membrane technologies.

Dr. Kostylev collaborates extensively with leading researchers in the field, including Stephen Strittmatter, Anthony Koleske, and Hideyuki Takahashi. His work appears in high-impact journals spanning neuroscience, biochemistry, and molecular biology disciplines. His research program represents an important contribution to understanding the fundamental mechanisms of neurodegenerative diseases and developing potential therapeutic approaches.